Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE

Matthew Greenhawt, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D. Arkwright, Philippe Bégin, Katharina Blümchen, Terri Brown‐Whitehorn, Heather Cassell, Edmond S. Chan, Christina E. Ciaccio, A. Deschildre, Amandine Divaret‐Chauveau, Stacy Dorris, Morna J. Dorsey, George Du Toit, Thomas Eiwegger, Michel Erlewyn‐Lajeunesse, David M. Fleischer, Lara S. Ford, Maria Garcia-Lloret, Jonathan O’B Hourihane, Nicola Jay, Stacie M. Jones, Edwin Kim, Kirsten M. Kloepfer, Stephanie A. Leonard, Guillaume Lezmi, Phil Lieberman, Jeanne Lomas, Melanie Makhija, Michael O’Sullivan, Christopher Parrish, Jane Peake, Kirsten P. Perrett, Daniel Petroni, Jacqueline A. Pongracic, Patrick Quinn, Rachel G. Robison, Georgiana Sanders, Lynda C. Schneider, Hemant Sharma, Sayantani Sindher, Juan Trujillo, Paul Turner, Katherine R. Tuttle, Julia Upton, Pooja Varshney, Brian P. Vickery, Christian Vogelberg, Brynn Wainstein, Julie Wang, Robert A. Wood, Katharine J. Bee, Dianne E. Campbell, Todd D. Green, R. Rouissi, Henry T. Bahnson, Timothée Bois, Hugh A. Sampson, A. Wesley Burks